Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

Subject : lymphomas

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study.

Authors : Stamatoullas, Aspasia¹ (AUTHOR); Ghesquières, Hervé² (AUTHOR); Feugier, Pierre³ (AUTHOR)

Source: Leukemia & Lymphoma. Dec2022, Vol. 63 Issue 13, p3063-3071. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Ifosfamide: des propriétés pharmacocinétiques intéressantes pour prévenir la survenue de métastases cérébrales dans certains cancers.

Authors : Lokiec, F.¹

Source: Oncologie (Tech Science Press). Nov2007, Vol. 9 Issue 11, p790-794. 5p. 4 Diagrams, 1 Chart.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma.

Authors : Biagi, J. J.¹; Herbert, K. E.¹; Smith, C.

Source: Leukemia & Lymphoma. Feb2005, Vol. 46 Issue 2, p197-206. 10p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Role of Ifosfamide in the Treatment of Lymphomas.

Authors : Hagemeister, Fredrick B.¹

Source: Leukemia & Lymphoma. Aug99, Vol. 34 Issue 5/6, p433-441. 9p. 4 Charts.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma.

Authors : Yang, Jianliang¹ (AUTHOR); Shi, Yuankai¹ (AUTHOR) ; He, Xiaohui¹ (AUTHOR)

Source: Leukemia & Lymphoma. Jul2015, Vol. 56 Issue 7, p2218-2221. 4p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.

Authors : Arellano-Rodrigo, Eduardo¹; López-Guillermo, Armando¹; Bessell, Eric M.²

Source: European Journal of Haematology. Apr2003, Vol. 70 Issue 4, p219-224. 6p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.

Authors : Elstrom, Rebecca L.¹ (AUTHOR); Andemariam, Biree^1,2 (AUTHOR); Martin, Peter¹ (AUTHOR)

Source: Leukemia & Lymphoma. Aug2012, Vol. 53 Issue 8, p1469-1473. 5p. 1 Chart, 3 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma

Authors : Lossos, Izidore S.^1,2 (AUTHOR) ; Hosein, Peter J.¹ (AUTHOR); Morgensztern, Daniel¹ (AUTHOR)

Source: Leukemia & Lymphoma. Mar2010, Vol. 51 Issue 3, p406-414. 9p. 1 Diagram, 3 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Ifosfamide, Epirubicin and Etoposide (IEV) Regimen as Salvage and Mobilization Therapy for Refractory or Early Relapsing Patients with Aggressive Non-Hodgkin's Lymphoma.

Authors : Pocalli, Barbara¹; De Simone, MariaCarla¹; Annunziata, Mario¹

Source: Leukemia & Lymphoma. Aug2004, Vol. 45 Issue 8, p1605-1609. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.

Authors : Mayer, J; Kořístek, Z; Vášová, I

Source: Bone Marrow Transplantation. 3/1/99, Vol. 23 Issue 5, p413. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study.

Ifosfamide: des propriétés pharmacocinétiques intéressantes pour prévenir la survenue de métastases cérébrales dans certains cancers.

A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma.

The Role of Ifosfamide in the Treatment of Lymphomas.

A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma.

Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.

Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.

Ifosfamide, Epirubicin and Etoposide (IEV) Regimen as Salvage and Mobilization Therapy for Refractory or Early Relapsing Patients with Aggressive Non-Hodgkin's Lymphoma.

Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.

اتصل بنا

اتبع